iShares Health Innovation Active ETF Rating $32.17 -0.18 (-0.56%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock iShares Health Innovation Active ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.67Holdings in BMED have an aggregate rating of Moderate Buy based on 498 analyst ratings issued in the past year covering 22 companies (70.6% of the portfolio).BMED Aggregate Price Target$32.17High Prediction$32.17Average Prediction$32.17Low Prediction$32.17Holdings in BMED have an aggregate price target of $32.17 and a range of $32.17 to $32.17 covering 22 companies (70.6% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 BMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.85%MRKMerck & Co., Inc.$135.78+0.2%4.3307 of 5 stars2.68$135.50 -0.2%22Trending NewsAnalyst ForecastInsider TradeAnalyst Revision4.87%GILDGilead Sciences$138.36+0.2%4.429 of 5 stars2.83$158.04 14.2%29Trending NewsAnalyst DowngradeOptions VolumeAnalyst Revision4.45%JNJJohnson & Johnson$260.44-0.6%4.7977 of 5 stars2.80$268.22 3.0%25Trending News4.43%EWEdwards Lifesciences$91.51-1.1%4.0973 of 5 stars2.74$100.27 9.6%23Positive News4.17%TMOThermo Fisher Scientific$588.17-1.3%4.6686 of 5 stars2.79$619.41 5.3%24Insider Trade3.72%CRLCharles River Laboratories International$279.70-0.6%1.7047 of 5 stars2.69$255.65 -8.6%16Insider Trade3.63%DHRDanaher$202.51-0.7%4.5026 of 5 stars2.84$228.91 13.0%253.58%BIIBBiogen$209.83-0.4%3.9844 of 5 stars2.58$227.07 8.2%33Analyst Downgrade3.50%ABBVAbbVie$249.20-0.6%4.9397 of 5 stars2.88$275.50 10.6%26Trending NewsAnalyst ForecastAnalyst Revision3.50%WATWaters$411.88-0.4%2.7283 of 5 stars2.75$420.35 2.1%20Positive NewsAnalyst Downgrade3.37%MTDMettler-Toledo International$1,417.40-0.9%3.093 of 5 stars2.46$1,461.27 3.1%13Positive News3.07%MRNAModerna$63.32-0.5%1.3479 of 5 stars1.88$42.13 -33.5%172.96%VRTXVertex Pharmaceuticals$505.75-2.1%4.4287 of 5 stars2.92$563.50 11.4%242.49%AMGNAmgen$415.21-0.6%3.8043 of 5 stars2.35$372.39 -10.3%31Analyst ForecastInsider Trade2.44%TECHBio-Techne$72.40+0.3%3.1822 of 5 stars2.06$68.92 -4.8%17Earnings ReportDividend AnnouncementAnalyst Downgrade2.39%ILMNIllumina$190.89-0.9%3.214 of 5 stars2.47$188.40 -1.3%17Positive News2.32%DXCMDexCom$89.75-1.9%4.2038 of 5 stars2.89$88.71 -1.2%27Analyst Upgrade2.17%INCYIncyte$120.16-0.3%3.5255 of 5 stars2.43$120.65 0.4%23Positive NewsAnalyst Forecast1.97%IQVIQVIA$236.18-2.2%4.2127 of 5 stars2.88$241.88 2.4%17Positive News1.94%ARGXargenex$851.29-0.7%4.7596 of 5 stars2.92$1,056.89 24.2%24Positive News1.89%NBIXNeurocrine Biosciences$152.72+1.3%4.9877 of 5 stars2.88$200.86 31.5%24Analyst Downgrade1.86%CYTKCytokinetics$74.13+0.9%3.5532 of 5 stars2.86$102.20 37.9%21Analyst ForecastAnalyst Revision This page (NYSEARCA:BMED) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour 10X AI demo is starting…Keith Kaplan, the AI expert behind tools used by more than 100000 investors, built his models with an investme...TradeSmith | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredWho Really Gets Rich from IPOs?Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...Weiss Ratings | SponsoredHow a rare metal shortage sent gains up 2512 percentIn 2010, a rare earth metal called dysprosium surged 2,512 percent in two and a half years after China cut exp...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMED Stock Alerts